Hyperparathyroidism, Primary

Endocrinology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Amgen
AmgenTHOUSAND OAKS, CA
1 program
CinacalcetN/A1 trial
Active Trials
NCT00928408Completed305Est. Feb 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AmgenCinacalcet

Clinical Trials (1)

Total enrollment: 305 patients across 1 trials

NCT00928408AmgenCinacalcet

PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice

Start: Oct 2009Est. completion: Feb 2012305 patients
N/ACompleted

Related Jobs in Endocrinology

Senior Scientist, Analytical Development

Neurocrine Biosciences
US CA San Diego
Yesterday
$111K - $151K/yr

Clinical Practice Liaison - Psych, Kansas

Neurocrine Biosciences
Kansas City, MO
Yesterday
$161K - $220K/yr

Medical Science Liaison/Sr. Medical Science Liaison

Neurocrine Biosciences
US NC Home Office
Yesterday
$161K - $220K/yr

Principal Scientist, Lead Generation Biology (Head of Biophysics/SPR Lab)

Neurocrine Biosciences
US CA San Diego
2d ago
$131K - $179K/yr

Long Term Care Account Specialist - Oceanside CA

Neurocrine Biosciences
Oceanside CA
2d ago
$123K - $168K/yr

Sr. Clinical Trials Manager

Neurocrine Biosciences
UK London
2d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Acromegaly(67)Growth Hormone Deficiency(39)Growth Hormone Disorder(37)Hypogonadism(21)Secondary Hyperparathyroidism(13)Hypoparathyroidism(12)Thyroid Eye Disease(11)Adult Growth Hormone Deficiency(10)Hypothyroidism(9)Cushing's Syndrome(9)